- with Synthélabo in 1999 to form
Sanofi-Synthélabo. In 2004,
Sanofi-Synthélabo
merged with
Aventis and
renamed to
Sanofi-Aventis,
which were each the product...
- 8437°E / 45.727; 4.8437
Sanofi Pasteur is the
vaccines division of the
French multinational pharmaceutical company Sanofi.
Sanofi Pasteur is the largest...
-
Zealand Pharma vil gøre sig fri af
Sanofis skygge |
Berlingske Business "Zealand
Pharma vil gøre sig fri af
Sanofis skygge". Berlingske.
August 21, 2014...
- With the new company's 2004
merger with
Sanofi-Synthélabo, it
became a
subsidiary of the
resulting Sanofi-Aventis
pharmaceuticals group. The company...
- The
Sanofi–GSK COVID-19 vaccine, sold
under the
brand name
VidPrevtyn Beta, is a COVID-19
vaccine developed by
Sanofi Pasteur and GSK. The
Sanofi–GSK...
-
aviation infrastructure, real estate, and fertilizer. He was the
chairman of
Sanofi India (previously
known as
Hoechst AG and Aventis) and the
chairman of Bayer...
- drug for the
treatment of
insomnia which was
being developed by
Sanofi Aventis.
Sanofi Aventis announced in
December 2009 that it was
withdrawing its application...
-
Amibegron (SR-58,611A) was a drug
developed by
Sanofi-Aventis (now
Sanofi)
which acts as a
selective agonist for the β3
adrenergic receptor. It is the...
-
shampoo now
owned by
Sanofi.
First made by
Abbott Laboratories, the
brand was
bought by
Chattem in 2002.
Chattem was
acquired by
Sanofi in 2010, although...
-
Department of
Health (DOH)
administered Sanofi Pasteur's
Dengvaxia to schoolchildren. The
program was
stopped when
Sanofi Pasteur advised the
government that...
